AJANTPHARM

Ajanta Pharma Share Price

 

 

Invest in Ajanta Pharma with 3.41X leverage

Invest with MTF

Performance

  • Low
  • ₹2,713
  • High
  • ₹2,824
  • 52 Week Low
  • ₹2,327
  • 52 Week High
  • ₹3,116
  • Open Price₹2,747
  • Previous Close₹2,668
  • Volume1,012,518

Investment Returns

  • Over 1 Month + 8.72%
  • Over 3 Month + 8.03%
  • Over 6 Month + 6.64%
  • Over 1 Year -2.47%

Smart Investing Starts Here Start SIP with Ajanta Pharma for Steady Growth!

Invest Now

Ajanta Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 35.1
  • PEG Ratio
  • 3.1
  • Market Cap Cr
  • 34,157
  • P/B Ratio
  • 7.9
  • Average True Range
  • 67.09
  • EPS
  • 77.93
  • Dividend Yield
  • 1
  • MACD Signal
  • 32.97
  • RSI
  • 67.19
  • MFI
  • 91.88

Ajanta Pharma Financials

Ajanta Pharma Technicals

EMA & SMA

Current Price
₹2,734.50
+ 66.4 (2.49%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹2,626.36
  • 50 Day
  • ₹2,578.32
  • 100 Day
  • ₹2,571.01
  • 200 Day
  • ₹2,591.71

Resistance and Support

2757.13 Pivot Speed
  • R3 2,912.47
  • R2 2,868.23
  • R1 2,801.37
  • S1 2,690.27
  • S2 2,646.03
  • S3 2,579.17

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ajanta Pharma is a specialty pharmaceutical company offering innovative, high-quality medicines across 30+ countries. With leadership in multiple therapeutic segments, Ajanta operates 7 state-of-the-art manufacturing facilities, supported by robust R&D capabilities and a strong global presence.

Ajanta Pharma has an operating revenue of Rs. 4,972.92 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 26% is great, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 5% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 52 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ajanta Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-03 Quarterly Results & Interim Dividend
2025-07-28 Quarterly Results & Others To consider other business matters. per share(475%)Interim Dividend
2025-04-30 Audited Results & A.G.M.
2025-01-30 Quarterly Results
2024-10-28 Quarterly Results
Date Purpose Remarks
2025-11-10 INTERIM Rs.28.00 per share(1400%)First Interim Dividend
2024-11-06 INTERIM Rs.28.00 per share(1400%)First Interim Dividend
2024-02-08 INTERIM Rs.26.00 per share(1300%)Second Interim Dividend
2023-08-04 SPECIAL Rs.15.00 per share(750%)Special Dividend
2023-08-04 INTERIM Rs.10.00 per share(500%)First Interim Dividend
View Ajanta Pharma Dividend History Arrow
Date Purpose Remarks
2022-06-23 Bonus Rs.0.00 issue in the ratio of 1:2 of Rs. 2/-.

Ajanta Pharma F&O

Ajanta Pharma Shareholding Pattern

66.25%
14.67%
2.64%
8.53%
0%
6.53%
1.38%

About Ajanta Pharma

  • NSE Symbol
  • AJANTPHARM
  • BSE Symbol
  • 532331
  • Managing Director
  • Mr. Yogesh M Agrawal
  • ISIN
  • INE031B01049

Similar Stocks to Ajanta Pharma

Ajanta Pharma FAQs

Ajanta Pharma share price is ₹2,734 As on 26 December, 2025 | 01:41

The Market Cap of Ajanta Pharma is ₹34157.2 Cr As on 26 December, 2025 | 01:41

The P/E ratio of Ajanta Pharma is 35.1 As on 26 December, 2025 | 01:41

The PB ratio of Ajanta Pharma is 7.9 As on 26 December, 2025 | 01:41

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23